[Form 4] Encompass Health Corporation Insider Trading Activity

Rhea-AI Filing Summary

Encompass Health Corp (EHC) insider Patrick W. Tuer, EVP and Chief Operating Officer, reported a sale of 1,020 shares of Encompass Health common stock on 08/27/2025 at a reported price of $123.59 per share. After the transaction, Mr. Tuer beneficially owned 18,846 shares. The Form 4 was signed by an attorney-in-fact, Patrick Darby, on behalf of the reporting person.

Positive

• Timely disclosure of insider transaction in compliance with Section 16
• Complete transaction details provided including date, price, amount sold, and resulting beneficial ownership

Negative

• Insider disposition: sale of 1,020 shares was reported
• No additional context (e.g., purpose of sale or aggregate holdings beyond post-transaction count) provided in the filing

Insights

Securities Analyst

TL;DR Insider sale of 1,020 shares was reported in compliance with Section 16.

The transaction is a straightforward disclosure of an insider disposition: 1,020 shares sold at $123.59, leaving 18,846 shares owned. The filing shows timely reporting and use of an attorney-in-fact to execute the form. Absent additional context on the reporting person's total holdings or recent pattern of trading, this single sale alone does not provide material information about company fundamentals.

Corporate Governance Expert

TL;DR The Form 4 indicates compliant disclosure practices but records an insider sale that investors may note.

The filing identifies the reporting person as EVP and COO and records the sale on 08/27/2025. Signature by an attorney-in-fact is properly indicated. From a governance perspective, the form meets reporting requirements by listing the transaction type, amount, price, and resulting beneficial ownership. The filing does not disclose any derivative activity or planned trading arrangement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	08/27/2025		S		1,020	D	$123.59	18,846	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Patrick W. Tuer report on Form 4 for EHC?

The Form 4 reports a sale of 1,020 shares of Encompass Health common stock on 08/27/2025 at $123.59 per share.

How many Encompass Health (EHC) shares does Patrick W. Tuer own after the reported sale?

After the reported transaction, Mr. Tuer beneficially owned 18,846 shares.

What is Patrick W. Tuer's role at Encompass Health as listed on the filing?

The filing lists Patrick W. Tuer as EVP, Chief Operating Officer of Encompass Health.

Who signed the Form 4 for Patrick W. Tuer?

The Form 4 was signed by Patrick Darby, attorney-in-fact, on behalf of Patrick W. Tuer on 08/27/2025.

Did the Form 4 report any derivative securities or 10b5-1 plan transactions?

No. The filing shows no derivative securities or indicated 10b5-1 plan transactions; it records a direct sale of common stock only.